Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: An open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers

MLA

Rhim, Si-Youn, et al. “Bioavailability and Bioequivalence of Two Oral Formulations of Alendronate Sodium 70 Mg: An Open-Label, Randomized, Two-Period Crossover Comparison in Healthy Korean Adult Male Volunteers.” Clinical Therapeutics, vol. 31, no. 5, May 2009, pp. 1037–45. EBSCOhost, https://doi.org/10.1016/j.clinthera.2009.05.001.

APA

Rhim, S.-Y., Park, J.-H., Park, Y.-S., Lee, M.-H., Kim, D.-S., Shaw, L. M., Yang, S.-C., & Kang, J.-S. (2009). Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: An open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers. Clinical Therapeutics, 31(5), 1037–1045. https://doi.org/10.1016/j.clinthera.2009.05.001

Chicago

Rhim, Si-Youn, Jin-Hee Park, Yoo-Sin Park, Min-Ho Lee, Dong-Sun Kim, Leslie M. Shaw, Seok-Chul Yang, and Ju-Seop Kang. 2009. “Bioavailability and Bioequivalence of Two Oral Formulations of Alendronate Sodium 70 Mg: An Open-Label, Randomized, Two-Period Crossover Comparison in Healthy Korean Adult Male Volunteers.” Clinical Therapeutics 31 (5): 1037–45. doi:10.1016/j.clinthera.2009.05.001.